The tri-nucleotide spacer sequence between estrogen response element half-sites is conserved and modulates ERα-mediated transcriptional responses

Journal of Steroid Biochemistry and Molecular Biology

Volumn 120, Issue 4-5, 2010, Pages 172-179

  Shu, Feng jue ^a   Sidell, Neil ^a   Yang, Danzhou ^b   Kallen, Caleb B ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

Author keywords

Estrogen; Estrogen receptor; Estrogen response element; Tri nucleotide spacer

Indexed keywords

ESTROGEN RECEPTOR ALPHA; HYDROXYTAMOXIFEN;

ARTICLE; BINDING AFFINITY; CELL STRAIN MCF 7; CONTROLLED STUDY; ESTROGEN RESPONSIVE ELEMENT; GENOMICS; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PREDICTION; PROTEIN DNA BINDING; TRANSACTIVATION; TRANSCRIPTION REGULATION;

CELL LINE; CELL LINE, TUMOR; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENETIC LOCI; HUMANS; PROTEIN BINDING; RESPONSE ELEMENTS; TRANSCRIPTION, GENETIC;

EID: 77953616459     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2010.04.009     Document Type: Article

References (66)

1. Yager J.D., Davidson N.E. Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 2006, 354(3):270-282.
2. Smith C.L., O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 2004, 25(1):45-71.
3. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 2005, 19(4):833-842.
4. Cerillo G., Rees A., Manchanda N., Reilly C., Brogan I., White A., Needham M. The oestrogen receptor regulates NFkappaB and AP-1 activity in a cell-specific manner. J. Steroid Biochem. Mol. Biol. 1998, 67(2):79-88.
5. Paech K., Webb P., Kuiper G.G., Nilsson S., Gustafsson J., Kushner P.J., Scanlan T.S. Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 1997, 277(5331):1508-1510.
6. Webb P., Nguyen P., Valentine C., Lopez G.N., Kwok G.R., McInerney E., Katzenellenbogen B.S., Enmark E., Gustafsson J.A., Nilsson S., Kushner P.J. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions. Mol. Endocrinol. 1999, 13(10):1672-1685.
7. Khan S., Abdelrahim M., Samudio I., Safe S. Estrogen receptor/Sp1 complexes are required for induction of cad gene expression by 17beta-estradiol in breast cancer cells. Endocrinology 2003, 144(6):2325-2335.
8. Kim K., Barhoumi R., Burghardt R., Safe S. Analysis of estrogen receptor alpha-Sp1 interactions in breast cancer cells by fluorescence resonance energy transfer. Mol. Endocrinol. 2005, 19(4):843-854.
9. Krishnan V., Wang X., Safe S. Estrogen receptor-Sp1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells. J. Biol. Chem. 1994, 269(22):15912-15917.
10. Safe S., Kim K. Non-classical genomic estrogen receptor (ER)/specificity protein and ER/activating protein-1 signaling pathways. J. Mol. Endocrinol. 2008, 41(5):263-275.
11. Hua S., Kallen C.B., Dhar R., Baquero M.T., Mason C.E., Russell B.A., Shah P.K., Liu J., Khramtsov A., Tretiakova M.S., Krausz T.N., Olopade O.I., Rimm D.L., White K.P. Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression. Mol. Syst. Biol. 2008, 4:188.
12. Laganiere J., Deblois G., Lefebvre C., Bataille A.R., Robert F., Giguere V. Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc. Natl. Acad. Sci. U.S.A. 2005, 102(33):11651-11656.
13. Carroll J.S., Meyer C.A., Song J., Li W., Geistlinger T.R., Eeckhoute J., Brodsky A.S., Keeton E.K., Fertuck K.C., Hall G.F., Wang Q., Bekiranov S., Sementchenko V., Fox E.A., Silver P.A., Gingeras T.R., Liu X.S., Brown M. Genome-wide analysis of estrogen receptor binding sites. Nat. Genet. 2006, 38(11):1289-1297.
14. Lin C.Y., Vega V.B., Thomsen J.S., Zhang T., Kong S.L., Xie M., Chiu K.P., Lipovich L., Barnett D.H., Stossi F., Yeo A., George J., Kuznetsov V.A., Lee Y.K., Charn T.H., Palanisamy N., Miller L.D., Cheung E., Katzenellenbogen B.S., Ruan Y., Bourque G., Wei C.L., Liu E.T. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet. 2007, 3(6):e87.
15. Kwon Y.S., Garcia-Bassets I., Hutt K.R., Cheng C.S., Jin M., Liu D., Benner C., Wang D., Ye Z., Bibikova M., Fan J.B., Duan L., Glass C.K., Rosenfeld M.G., Fu X.D. Sensitive ChIP-DSL technology reveals an extensive estrogen receptor alpha-binding program on human gene promoters. Proc. Natl. Acad. Sci. U.S.A. 2007, 104(12):4852-4857.
16. Lupien M., Brown M. Cistromics of hormone-dependent cancer. Endocr. Relat. Cancer. 2009, 16(2):381-389.
17. Lupien M., Eeckhoute J., Meyer C.A., Krum S.A., Rhodes D.R., Liu X.S., Brown M. Coactivator function defines the active estrogen receptor alpha cistrome. Mol. Cell. Biol. 2009, 29(12):3413-3423.
18. Kininis M., Chen B.S., Diehl A.G., Isaacs G.D., Zhang T., Siepel A.C., Clark A.G., Kraus W.L. Genomic analyses of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Mol. Cell. Biol. 2007, 27(14):5090-5104.
19. Barnett D.H., Sheng S., Charn T.H., Waheed A., Sly W.S., Lin C.Y., Liu E.T., Katzenellenbogen B.S. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer. Cancer Res. 2008, 68(9):3505-3515.
20. Sun J., Nawaz Z., Slingerland J.M. Long-range activation of GREB1 by estrogen receptor via three distal consensus estrogen-responsive elements in breast cancer cells. Mol. Endocrinol. 2007, 21(11):2651-2662.
21. Hu Q., Kwon Y.S., Nunez E., Cardamone M.D., Hutt K.R., Ohgi K.A., Garcia-Bassets I., Rose D.W., Glass C.K., Rosenfeld M.G., Fu X.D. Enhancing nuclear receptor-induced transcription requires nuclear motor and LSD1-dependent gene networking in interchromatin granules. Proc. Natl. Acad. Sci. U.S.A. 2008, 105(49):19199-19204.
22. Klein-Hitpass L., Ryffel G.U., Heitlinger E., Cato A.C. A 13bp palindrome is a functional estrogen responsive element and interacts specifically with estrogen receptor. Nucleic Acids Res. 1988, 16(2):647-663.
23. Walker P., Germond J.E., Brown-Luedi M., Givel F., Wahli W. Sequence homologies in the region preceding the transcription initiation site of the liver estrogen-responsive vitellogenin and apo-VLDLII genes. Nucleic Acids Res. 1984, 12(22):8611-8626.
24. Klinge C.M. Estrogen receptor interaction with estrogen response elements. Nucleic Acids Res. 2001, 29(14):2905-2919.
25. Bourdeau V., Deschenes J., Metivier R., Nagai Y., Nguyen D., Bretschneider N., Gannon F., White J.H., Mader S. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 2004, 18(6):1411-1427.
26. Tang S., Tan S.L., Ramadoss S.K., Kumar A.P., Tang M.H., Bajic V.B. Computational method for discovery of estrogen responsive genes. Nucleic Acids Res. 2004, 32(21):6212-6217.
27. Bourdeau V., Deschenes J., Laperriere D., Aid M., White J.H., Mader S. Mechanisms of primary and secondary estrogen target gene regulation in breast cancer cells. Nucleic Acids Res. 2007.
28. Kamalakaran S., Radhakrishnan S.K., Beck W.T. Identification of estrogen-responsive genes using a genome-wide analysis of promoter elements for transcription factor binding sites. J. Biol. Chem. 2005, 280(22):21491-21497.
29. Gruber C.J., Gruber D.M., Gruber I.M., Wieser F., Huber J.C. Anatomy of the estrogen response element. Trends Endocrinol. Metab. 2004, 15(2):73-78.
30. O'Lone R., Frith M.C., Karlsson E.K., Hansen U. Genomic targets of nuclear estrogen receptors. Mol. Endocrinol. 2004, 18(8):1859-1875.
31. Driscoll M.D., Sathya G., Muyan M., Klinge C.M., Hilf R., Bambara R.A. Sequence requirements for estrogen receptor binding to estrogen response elements. J. Biol. Chem. 1998, 273(45):29321-29330.
32. Kulakosky P.C., McCarty M.A., Jernigan S.C., Risinger K.E., Klinge C.M. Response element sequence modulates estrogen receptor alpha and beta affinity and activity. J. Mol. Endocrinol. 2002, 29(1):137-152.
33. Nardulli A.M., Romine L.E., Carpo C., Greene G.L., Rainish B. Estrogen receptor affinity and location of consensus and imperfect estrogen response elements influence transcription activation of simplified promoters. Mol. Endocrinol. 1996, 10(6):694-704.
34. Wu F., Khan S., Wu Q., Barhoumi R., Burghardt R., Safe S. Ligand structure-dependent activation of estrogen receptor alpha/Sp by estrogens and xenoestrogens. J. Steroid Biochem. Mol. Biol. 2008, 110(1-2):104-115.
35. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 2000, 103(6):843-852.
36. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistlinger T.R., Fox E.A., Silver P.A., Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122(1):33-43.
37. Gevry N., Hardy S., Jacques P.E., Laflamme L., Svotelis A., Robert F., Gaudreau L. Histone H2A.Z is essential for estrogen receptor signaling. Genes Dev. 2009, 23(13):1522-1533.
38. Welboren W.J., van Driel M.A., Janssen-Megens E.M., van Heeringen S.J., Sweep F.C., Span P.N., Stunnenberg H.G. ChIP-Seq of ERalpha and RNA polymerase II defines genes differentially responding to ligands. EMBO J. 2009.
39. Krum S.A., Miranda-Carboni G.A., Lupien M., Eeckhoute J., Carroll J.S., Brown M. Unique ERalpha cistromes control cell type-specific gene regulation. Mol. Endocrinol. 2008, 22(11):2393-2406.
40. Deschenes J., Bourdeau V., White J.H., Mader S. Regulation of GREB1 transcription by estrogen receptor alpha through a multipartite enhancer spread over 20kb of upstream flanking sequences. J. Biol. Chem. 2007, 282(24):17335-17339.
41. Perillo B., Ombra M.N., Bertoni A., Cuozzo C., Sacchetti S., Sasso A., Chiariotti L., Malorni A., Abbondanza C., Avvedimento E.V. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 2008, 319(5860):202-206.
42. Mason C.E., Feng-Jue S., Wang C., Session R.M., Kallen R.G., Sidell N., Yu T., Liu M.H., Cheung E., Kallen C.B. Location analysis for the estrogen receptor-(reveals binding to diverse ERE sequences and widespread binding within repetitive DNA elements. Nucleic Acids Res. 2010, 38(7):2355-2368. Epub 2010 Jan 4.
43. Wang C., Yu J., Kallen C.B. Two estrogen response element sequences near the PCNA gene are not responsible for its estrogen-enhanced expression in MCF7 cells. PLoS ONE 2008, 3(10):e3523.
44. Krikun G., Mor G., Alvero A., Guller S., Schatz F., Sapi E., Rahman M., Caze R., Qumsiyeh M., Lockwood C.J. A novel immortalized human endometrial stromal cell line with normal progestational response. Endocrinology 2004, 145(5):2291-2296.
45. Schug J. Using TESS to Predict Transcription Factor Binding Sites in DNA Sequence 2008, John Wiley and Sons.
46. Schwabe J.W., Chapman L., Finch J.T., Rhodes D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 1993, 75(3):567-578.
47. Schwabe J.W., Chapman L., Finch J.T., Rhodes D., Neuhaus D. DNA recognition by the oestrogen receptor: from solution to the crystal. Structure 1993, 1(3):187-204.
48. Schwabe J.W., Fairall L., Chapman L., Finch J.T., Dutnall R.N., Rhodes D. The cocrystal structures of two zinc-stabilized DNA-binding domains illustrate different ways of achieving sequence-specific DNA recognition. Cold Spring Harb. Symp. Quant. Biol. 1993, 58:141-147.
49. Frasor J., Chang E.C., Komm B., Lin C.Y., Vega V.B., Liu E.T., Miller L.D., Smeds J., Bergh J., Katzenellenbogen B.S. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 2006, 66(14):7334-7340.
50. Group E.B.C.T.C. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998, 351(9114):1451-1467.
51. Kisanga E.R., Gjerde J., Guerrieri-Gonzaga A., Pigatto F., Pesci-Feltri A., Robertson C., Serrano D., Pelosi G., Decensi A., Lien E.A. Tamoxifen and metabolite concentrations in serum and breast cancer tissue during three dose regimens in a randomized preoperative trial. Clin. Cancer Res. 2004, 10(7):2336-2343.
52. Krieg A.J., Krieg S.A., Ahn B.S., Shapiro D.J. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J. Biol. Chem. 2004, 279(6):5025-5034.
53. Osborne C.K., Wiebe V.J., McGuire W.L., Ciocca D.R., DeGregorio M.W. Tamoxifen and the isomers of 4-hydroxytamoxifen in tamoxifen-resistant tumors from breast cancer patients. J. Clin. Oncol. 1992, 10(2):304-310.
54. Osborne C.K., Coronado E., Allred D.C., Wiebe V., DeGregorio M. Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen. J. Natl. Cancer Inst. 1991, 83(20):1477-1482.
55. Johnson M.D., Zuo H., Lee K.H., Trebley J.P., Rae J.M., Weatherman R.V., Desta Z., Flockhart D.A., Skaar T.C. Pharmacological characterization of 4-hydroxy-N-desmethyl tamoxifen, a novel active metabolite of tamoxifen. Breast Cancer Res. Treat. 2004, 85(2):151-159.
56. Tanay A. Extensive low-affinity transcriptional interactions in the yeast genome. Genome Res. 2006, 16(8):962-972.
57. Badis G., Berger M.F., Philippakis A.A., Talukder S., Gehrke A.R., Jaeger S.A., Chan E.T., Metzler G., Vedenko A., Chen X., Kuznetsov H., Wang C.F., Coburn D., Newburger D.E., Morris Q., Hughes T.R., Bulyk M.L. Diversity and complexity in DNA recognition by transcription factors. Science 2009, 324(5935):1720-1723.
58. Loven M.A., Likhite V.S., Choi I., Nardulli A.M. Estrogen response elements alter coactivator recruitment through allosteric modulation of estrogen receptor beta conformation. J. Biol. Chem. 2001, 276(48):45282-45288.
59. Loven M.A., Wood J.R., Nardulli A.M. Interaction of estrogen receptors alpha and beta with estrogen response elements. Mol. Cell. Endocrinol. 2001, 181(1-2):151-163.
60. Wood J.R., Greene G.L., Nardulli A.M. Estrogen response elements function as allosteric modulators of estrogen receptor conformation. Mol. Cell. Biol. 1998, 18(4):1927-1934.
61. Wood J.R., Likhite V.S., Loven M.A., Nardulli A.M. Allosteric modulation of estrogen receptor conformation by different estrogen response elements. Mol. Endocrinol. 2001, 15(7):1114-1126.
62. Nardulli A.M., Shapiro D.J. Binding of the estrogen receptor DNA-binding domain to the estrogen response element induces DNA bending. Mol. Cell. Biol. 1992, 12(5):2037-2042.
63. Kerppola T.K., Curran T. DNA bending by Fos and Jun: the flexible hinge model. Science 1991, 254(5035):1210-1214.
64. Ramirez-Carrozzi V.R., Kerppola T.K. Dynamics of Fos-Jun-NFAT1 complexes. Proc. Natl. Acad. Sci. U.S.A. 2001, 98(9):4893-4898.
65. Shiau A.K., Barstad D., Loria P.M., Cheng L., Kushner P.J., Agard D.A., Greene G.L. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen. Cell 1998, 95(7):927-937.
66. Tolstorukov M.Y., Kharchenko P.V., Goldman J.A., Kingston R.E., Park P.J. Comparative analysis of H2A.Z nucleosome organization in the human and yeast genomes. Genome Res. 2009, 19(6):967-977.